publication venue for
- Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.. 1518:209-225. 2022
- Extending human healthspan and longevity: a symposium report.. 1507:70-83. 2021
- Alternatives to amyloid for Alzheimer's disease therapies-a symposium report.. 1475:3-14. 2020
- Adult stem cells and regenerative medicine-a symposium report.. 1462:27-36. 2019
- Neuroimaging, neuromodulation, and population health: the neuroscience of chronic disease prevention.. 1428:240-256. 2018
- Disease drivers of aging.. 1386:45-68. 2016
- Alzheimer's disease research and development: a call for a new research roadmap.. 1-16. 2014
- Hypoxia-induced phrenic long-term facilitation: emergent properties.. 143-53. 2013
- Potential role of immunosenescence in cancer development.. 158-65. 2010
- Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study .. 273-7. 2009
- Mitochondrial and nuclear cross talk in cell death: parthanatos.. 233-41. 2008
- Stress-induced alternative splicing modulations in brain and periphery: acetylcholinesterase as a case study.. 269-81. 2008
- Do membrane rafts contribute to human immunosenescence?. 98-110. 2007
- Attenuation of experimental aortic aneurysm formation in P-selectin knockout mice.. 353-9. 2006
- Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms.. 367-79. 2006
- Low-grade inflammation with aging has consequences for T-lymphocyte signaling.. 125-33. 2004
- From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses.. 85-98. 2004
- Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease.. 132-9. 2003
- The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.. 80-92. 2003
- An empirical model of gamma-secretase activity.. 233-40. 2000
- Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke.. 433-6. 1997
- Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease.. 6-15. 1996
- Molecular mechanisms of nitric oxide actions in the brain.. 76-85. 1994
- The effect of hemorrhagic hypotension and retransfusion and 7-nitro-indazole on rCBF, NOS catalytic activity, and cortical NO content in the cat.. 348-68. 1994
- Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.. 103-8. 1993
- Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives.. 138-48. 1992
- Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier.. 145-8. 1991